STAMFORD, Conn., July 30 /PRNewswire-FirstCall/ -- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (OTCQB:SPDE), today announced that the VA Palo Alto Health Care System (VAPAHCS), a northern California based hospital group that is part of The Department of Veterans Affairs (VA) nationwide network of hospitals, recently purchased
The VA Palo Alto Health Care System (VAPAHCS) consists of three inpatient facilities and seven outpatient clinics located in Palo Alto, California and the surrounding region. Affiliated with the Stanford University School of Medicine, VAPAHCS is also a teaching hospital, providing a full range of patient care services with state-of-the-art technology as well as education and research. VAPAHCS serves more than 85,000 enrolled veterans.
The Zargis Cardioscan heart sound analysis software is designed to help healthcare practitioners analyze cardiac sounds for the identification and classification of suspected heart murmurs, which can be signs of heart disease. In conjunction with the Web-enabled TeleSteth™ platform, the system also allows healthcare professionals to transmit physiological sounds to colleagues located anywhere in the world.
“This order represents the first acquisition of Zargis Cardioscan units by the Veterans Administration,” commented Zargis CEO John Kallassy. “We are optimistic that this implementation at the VA Palo Alto Health Care System will generate interest from other members of the VA’s vast nationwide network of healthcare facilities about incorporating Zargis Cardioscan into their patient care.”
The mission of The Department of Veterans Affairs (VA) is to serve America's more than 23-million Veterans and their families with dignity and compassion and to be their principal advocate in ensuring that they receive medical care, benefits, social support, and lasting memorials promoting the health, welfare, and dignity of all Veterans in recognition of their service to this Nation. The VA is the second largest Federal department. Services and benefits are provided through a nationwide network of 153 hospitals, 956 outpatient clinics, 134 community living centers, 90 domiciliary residential rehabilitation treatment programs, 232 Vet centers, 57 Veterans benefits regional offices, and 131 national cemeteries.
About Zargis Medical Corp.
Zargis is a global medical device company focused on improving health outcomes and cost-effectiveness through diagnostic support software and innovation. Zargis is majority-owned by Speedus Corp. (OTCQB: SPDE), and both 3M Company and Siemens Corporate Research, a division of Siemens AG (NYSE: SI), hold equity positions.
For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or [email protected], or visit the following Web sites: www.zargis.com and www.speedus.com.
Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.
SOURCE Speedus Corp.
Subscribe to our Free Newsletters!
Erythropoietin is a hormone secreted by kidneys in response to low oxygen levels in tissues ...
Local anesthesia is a type of anesthesia generally used to block pain sensation only in a specific ...
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...View All